BofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $21.00 (from $18.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Piper Sandler Reiterates Neutral Rating on Hims and Hers (HIMS), PT $24February 21, 2025 12:23 PM Why Morgan Stanley is cautious on Hims & Hers sharesFebruary 20, 2025 4:00 PM Hims & Hers Health, Inc. (HIMS) options active on 349K contracts amid sharp rallyFebruary 20, 2025 5:17 AM Form 144 Hims & Hers Health, Inc. Filed by: Chi MichaelFebruary 19, 2025 10:17 AM Hims & Hers Health (HIMS) Acquires At-Home Lab Testing FacilityFebruary 19, 2025 9:01 AM Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for SubscribersFebruary 19, 2025 9:00 AM Hims & Hers Health, Inc. (HIMS) options active on volume of 106K contracts amid wide price movementFebruary 19, 2025 4:54 AM Hims and Hers (HIMS) PT Raised to $68 at Canaccord GenuityFebruary 19, 2025 12:16 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.5 puts with a focus on February 28 weekly putsFebruary 18, 2025 2:47 PM Form 144 Hims & Hers Health, Inc. Filed by: Boughton SoleilFebruary 18, 2025 11:22 AM Form 144 Hims & Hers Health, Inc. Filed by: Dudum AndrewFebruary 18, 2025 11:11 AM Morgan Stanley downgrades Hims&Hers on valuation concernsFebruary 18, 2025 9:56 AM Hims and Hers (HIMS) PT Raised to $85 at BTIGFebruary 18, 2025 5:20 AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price upFebruary 18, 2025 4:42 AM